Additionally, their study demonstrated fluoxetine’s ability to inhibit tumour microvascular formation around the crypts by reducing vascular epidermal growth factor (VEGF) secretion and constricting tumour arterioles, leading to suppressed tumour proliferation and growth [57]. Here, VEGFA is linked to neoplasm.